The Drug Controller General of India authorized the country’s first nasal spray vaccine "under Restricted Use in Emergency Situations for ages 18 and above," marking a big step toward increasing the availability of needle-free vaccines around the world. Washington University St. Louis, which had created and developed the recombinant adenoviral...
India to Streamline Regulatory Oversight of Medical Devices
India's Central Drugs Standard Control Organization (CDSCO), the national regulatory authority for drugs and medical devices, is now acting on a report submitted by the Drugs Technical Advisory Board (DTAB) — the country’s highest statutory decision-making body on technical matters related to medicines and medical devices. According to the proposal...